Lombard Odier Asset Management (Switzerland)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.01M Buy
57,445
+3,801
+7% +$532K 0.3% 75
2025
Q4
$6.58M Buy
53,644
+100
+0.2% +$12.2K 0.28% 78
2025
Q3
$5.94M Buy
53,544
+232
+0.4% +$26.4K 0.27% 85
2025
Q2
$5.91M Buy
53,312
+10,535
+25% +$1.12M 0.3% 77
2025
Q1
$4.79M Buy
42,777
+8,788
+26% +$907K 0.28% 91
2024
Q4
$3.14M Buy
33,989
+2,642
+8% +$238K 0.23% 112
2024
Q3
$2.63M Buy
31,347
+104
+0.3% +$7.94K 0.22% 119
2024
Q2
$2.14M Buy
31,243
+16
+0.1% +$1.07K 0.22% 103
2024
Q1
$2.29M Buy
31,227
+19,122
+158% +$1.47M 0.16% 139
2023
Q4
$981K Sell
12,105
-3,341
-22% -$260K 0.13% 129
2023
Q3
$1.16M Buy
15,446
+1,642
+12% +$126K 0.19% 96
2023
Q2
$1.06M Buy
13,804
+1,923
+16% +$153K 0.15% 109
2023
Q1
$986K Buy
11,881
+551
+5% +$45.6K 0.09% 197
2022
Q4
$973K Buy
11,330
+6,825
+151% +$540K 0.08% 186
2022
Q3
$278K Sell
4,505
-10,318
-70% -$651K 0.02% 232
2022
Q2
$916K Buy
+14,823
New +$918K 0.08% 159
2022
Q1
Sell
-13,883
Closed -$1.01M 255
2021
Q4
$1.01M Sell
13,883
-679
-5% -$46.8K 0.06% 142
2021
Q3
$963K Buy
14,562
+321
+2% +$22.6K 0.06% 150
2021
Q2
$981K Buy
14,241
+3,741
+36% +$250K 0.05% 199
2021
Q1
$679K Sell
10,500
-1,404
-12% -$90.5K 0.05% 203
2020
Q4
$694K Sell
11,904
-13,240
-53% -$799K 0.08% 96
2020
Q3
$1.59M Buy
25,144
+6,247
+33% +$433K 0.17% 93
2020
Q2
$1.45M Sell
18,897
-5,480
-22% -$420K 0.23% 74
2020
Q1
$1.82M Buy
24,377
+7,376
+43% +$510K 0.24% 63
2019
Q4
$1.1M Buy
17,001
+675
+4% +$44K 0.1% 169
2019
Q3
$1.03M Buy
16,326
+362
+2% +$23.7K 0.11% 159
2019
Q2
$1.08M Buy
15,964
+1,500
+10% +$98.7K 0.11% 162
2019
Q1
$940K Sell
14,464
-23,745
-62% -$1.58M 0.1% 169
2018
Q4
$2.39M Buy
38,209
+26,873
+237% +$1.88M 0.27% 71
2018
Q3
$875K Buy
11,336
+7,021
+163% +$530K 0.09% 190
2018
Q2
$306K Hold
4,315
0.03% 255
2018
Q1
$325K Sell
4,315
-1,814
-30% -$144K 0.03% 287
2017
Q4
$439K Sell
6,129
-102,000
-94% -$7.75M 0.04% 242
2017
Q3
$8.76M Buy
108,129
+102,000
+1,664% +$7.8M 0.85% 33
2017
Q2
$434K Hold
6,129
0.05% 258
2017
Q1
$416K Buy
+6,129
New +$431K 0.05% 268
2016
Q3
Sell
-6,129
Closed -$511K 171
2016
Q2
$511K Sell
6,129
-1,844
-23% -$164K 0.07% 192
2016
Q1
$732K Hold
7,973
0.09% 170
2015
Q4
$816K Hold
7,973
0.1% 125
2015
Q3
$786K Sell
7,973
-9,998
-56% -$1.11M 0.07% 119
2015
Q2
$2.1M Buy
17,971
+3,900
+28% +$426K 0.16% 65
2015
Q1
$1.39M Buy
+14,071
New +$1.43M 0.15% 97
2014
Q4
Sell
-338,275
Closed -$36.1M 514
2014
Q3
$36.1M Buy
338,275
+322,302
+2,018% +$31.6M 0.93% 15
2014
Q2
$1.32M Buy
+15,973
New +$1.24M 0.15% 83

Other funds holding GILD

Lombard Odier Asset Management (Switzerland)'s GILD Position: Q1 2026 in Review

Lombard Odier Asset Management (Switzerland) increased its Gilead Sciences (GILD) stake by 7.1% in Q1 2026, buying an estimated $532K and bringing the position to 57,445 shares worth $8.01M. The position accounts for 0.3% of the portfolio, ranked #75.

Lombard Odier Asset Management (Switzerland) first reported a position in GILD in Q2 2014 and has held it in 44 quarters since. The position peaked at $36.1M in Q3 2014. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Lombard Odier Asset Management (Switzerland) held 57,445 shares of Gilead Sciences worth $8.01M as of Q1 2026.
  • Lombard Odier Asset Management (Switzerland) bought 3,801 Gilead Sciences shares in Q1 2026, an estimated $532K.
  • Gilead Sciences made up 0.3% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q1 2026, its #75 holding.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Gilead Sciences in Q2 2014 and has held it in 44 quarters since.
  • Lombard Odier Asset Management (Switzerland)'s Gilead Sciences position peaked at $36.1M in Q3 2014.
  • 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2026, filed 15 May 2026.